Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Liver Surgery Boosts Bowel Cancer Survival Rate

By HospiMedica International staff writers
Posted on 16 Jun 2010
A new study shows that liver resection in patients with stage IV bowel cancer can boost five-year survival rate by almost 46%. More...


Researchers of the United Kingdom National Cancer Intelligence Network (NCIN; London) conducted a population-based study that followed 114,155 patients identified via the National Cancer Data Repository who underwent surgery for colorectal cancer between January 1998 and June 2004, of whom 3,116 (2.7%) subsequently had one or more hepatic resections; the hepatectomy rate increased from 1.7% in 1998 to 3.8% in 2004. All episodes of care in the 3 years after the initial operation were examined to determine the frequency of liver resection, and variations in the use of liver resection and survival were assessed.

The researchers found there was significant variation in the rate of liver resection across cancer networks and hospitals; the crude 5-year survival rate after liver resection was 44.2% from the time of hepatectomy and 45.9% from the time of colectomy. This was comparable to the 5-year survival rate of patients with stage III disease (42.2%). The study was published online on June 2, 2010, in the British Journal of Surgery.

"This surgery is very skilled and should be undertaken by expert surgeons working in specialist liver units,” said lead author Eva Morris, M.D., of the University of Leeds (United Kingdom). "We must work towards ensuring that all patients who need liver resections can access these services.”

Although first performed in 1943, the liver resection technique only became accepted practice in the mid 1990's, as initially it was very high-risk surgery. It ultimately became the gold standard treatment for bowel cancer that has spread to the liver in 2004.

Related Links:

United Kingdom National Cancer Intelligence Network
University of Leeds



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The device is worn on a finger and measures blood pressure without an arm‑compressing cuff (Photo courtesy of Sky Labs)

Ring-Type Cuffless Monitor Becomes First Added to Official Hypertension Guidelines

Detecting nocturnal and morning hypertension often requires out-of-office assessment, but conventional cuff-type monitors can disrupt sleep. New national guidance in South Korea expands 24-hour monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.